Skip to main content
Top
Published in: BMC Public Health 1/2006

Open Access 01-12-2006 | Research article

Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002

Authors: Jesús de Pedro-Cuesta, Markus Glatzel, Javier Almazán, Katharina Stoeck, Vittorio Mellina, Maria Puopolo, Maurizio Pocchiari, Inga Zerr, Hans A Kretszchmar, Jean-Philippe Brandel, Nicole Delasnerie-Lauprêtre, Annick Alpérovitch, Cornelia Van Duijn, Pascual Sanchez-Juan, Steven Collins, Victoria Lewis, Gerard H Jansen, Michael B Coulthart, Ellen Gelpi, Herbert Budka, Eva Mitrova

Published in: BMC Public Health | Issue 1/2006

Login to get access

Abstract

Background

The objective of this study was to describe the diagnostic panorama of human transmissible spongiform encephalopathies across 11 countries.

Methods

From data collected for surveillance purposes, we describe annual proportions of deaths due to different human transmissible spongiform encephalopathies in eleven EUROCJD-consortium countries over the period 1993–2002, as well as variations in the use of diagnostic tests. Using logistic models we quantified international differences and changes across time.

Results

In general, pre-mortem use of diagnostic investigations increased with time. International differences in pathological confirmation of sporadic Creutzfeldt-Jakob disease, stable over time, were evident. Compared to their counterparts, some countries displayed remarkable patterns, such as: 1) the high proportion, increasing with time, of variant Creutzfeldt-Jakob disease in the United Kingdom, (OR 607.99 95%CI 84.72–4363.40), and France (OR 18.35, 95%CI 2.20–152.83); 2) high, decreasing proportions of iatrogenic Creutzfeldt-Jakob disease in France, (OR 5.81 95%CI 4.09–8.24), and the United Kingdom, (OR 1.54 95%CI 1.03–2.30); and, 3) high and stable ratios of genetic forms in Slovakia (OR 21.82 95%CI 12.42–38.33) and Italy (OR 2.12 95%CI 1.69–2.68).

Conclusion

Considerable international variation in aetiological subtypes of human transmissible spongiform encephalopathies was evident over the observation period. With the exception of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease in France and the United Kingdom, these differences persisted across time.
Appendix
Available only for authorised users
Literature
2.
go back to reference Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB: Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A. 1999, 96: 15137-15142. 10.1073/pnas.96.26.15137.CrossRefPubMedPubMedCentral Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB: Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A. 1999, 96: 15137-15142. 10.1073/pnas.96.26.15137.CrossRefPubMedPubMedCentral
3.
go back to reference Will RG, Ironside J, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996, 347: 921-925. 10.1016/S0140-6736(96)91412-9.CrossRefPubMed Will RG, Ironside J, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996, 347: 921-925. 10.1016/S0140-6736(96)91412-9.CrossRefPubMed
4.
go back to reference Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996, 335: 924-930. 10.1056/NEJM199609263351303.CrossRefPubMed Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996, 335: 924-930. 10.1056/NEJM199609263351303.CrossRefPubMed
5.
go back to reference Zerr I, Pocchiari M, Collins S, Brandel JP, Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000, 55: 811-815.CrossRefPubMed Zerr I, Pocchiari M, Collins S, Brandel JP, Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000, 55: 811-815.CrossRefPubMed
6.
go back to reference Zerr I, Giese A, Windl O, Kropp.S., Schulz-Schaeffer WJ, Riedemann C, Skworc F, Bodemer M, Kretzschmar HA, Poser S: Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology. 1998, 51: 1398-1405.CrossRefPubMed Zerr I, Giese A, Windl O, Kropp.S., Schulz-Schaeffer WJ, Riedemann C, Skworc F, Bodemer M, Kretzschmar HA, Poser S: Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology. 1998, 51: 1398-1405.CrossRefPubMed
7.
go back to reference Ladogana A, Puopolo M, Croes E, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Lauprêtre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, de Pedro-Cuesta J, Martínez-Martín P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I: Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005, 64: 1586-1591. 10.1212/01.WNL.0000160117.56690.B2.CrossRefPubMed Ladogana A, Puopolo M, Croes E, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Lauprêtre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, de Pedro-Cuesta J, Martínez-Martín P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I: Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005, 64: 1586-1591. 10.1212/01.WNL.0000160117.56690.B2.CrossRefPubMed
8.
go back to reference Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Lauprêtre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrová E, Martínez-Martín J, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG: Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004, 127: 2348-2359. 10.1093/brain/awh249.CrossRefPubMed Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Lauprêtre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrová E, Martínez-Martín J, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG: Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004, 127: 2348-2359. 10.1093/brain/awh249.CrossRefPubMed
9.
go back to reference Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, Will R, Alperovitch A: Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet. 2003, 362: 128-130. 10.1016/S0140-6736(03)13867-6.CrossRefPubMed Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, Will R, Alperovitch A: Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet. 2003, 362: 128-130. 10.1016/S0140-6736(03)13867-6.CrossRefPubMed
10.
go back to reference Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn CM, Collins SJ, Boyd A, Guilivi A, Delasnerie-Lauprêtre N, Brandel JP, Zerr I, Kretzschmar H, Pedro-Cuesta J, Calero M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrová E: Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118: 166-174. 10.1007/s00439-005-0020-1.CrossRefPubMed Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn CM, Collins SJ, Boyd A, Guilivi A, Delasnerie-Lauprêtre N, Brandel JP, Zerr I, Kretzschmar H, Pedro-Cuesta J, Calero M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrová E: Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118: 166-174. 10.1007/s00439-005-0020-1.CrossRefPubMed
12.
go back to reference Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens SN, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004, 363: 147-421. 10.1016/S0140-6736(04)15486-X.CrossRef Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens SN, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004, 363: 147-421. 10.1016/S0140-6736(04)15486-X.CrossRef
13.
go back to reference Asante EA, Linehan JM, Desbruslais M, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JDF, Collinge J: BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 2002, 21: 6358-6366. 10.1093/emboj/cdf653.CrossRefPubMedPubMedCentral Asante EA, Linehan JM, Desbruslais M, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JDF, Collinge J: BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 2002, 21: 6358-6366. 10.1093/emboj/cdf653.CrossRefPubMedPubMedCentral
14.
go back to reference Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Collinge J, Diringer H, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO: Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995, 5: 575-582. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Collinge J, Diringer H, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO: Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995, 5: 575-582.
15.
go back to reference Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K, Green AJE, Knight RSG: Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000, 47: 575-582. 10.1002/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W.CrossRefPubMed Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K, Green AJE, Knight RSG: Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000, 47: 575-582. 10.1002/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W.CrossRefPubMed
16.
go back to reference Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T: Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996, 53: 162-166.CrossRefPubMed Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T: Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996, 53: 162-166.CrossRefPubMed
17.
go back to reference Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight RSG, Will RG: MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol. 2001, 56: 726-739. 10.1053/crad.2001.0771.CrossRefPubMed Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight RSG, Will RG: MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol. 2001, 56: 726-739. 10.1053/crad.2001.0771.CrossRefPubMed
18.
go back to reference Radbauer C, Hainfellner JA, Jellinger K, Pilz P, Maier H, Kleinert R, Budka H: Epidemiologie der übertragbaren spongiformen Enzephalopathien (Prion-Krankheiten)in Österreich. Wien Med Wochenschr. 1998, 148: 101-106.PubMed Radbauer C, Hainfellner JA, Jellinger K, Pilz P, Maier H, Kleinert R, Budka H: Epidemiologie der übertragbaren spongiformen Enzephalopathien (Prion-Krankheiten)in Österreich. Wien Med Wochenschr. 1998, 148: 101-106.PubMed
19.
go back to reference Huillard d'Aignaux J, Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, Peoc'h K, Salomon D, Hauw JJ, Alperovitch A: Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7. J Neurol Neurosurg Psychiatry. 2000, 68: 787-789. 10.1136/jnnp.68.6.787.CrossRef Huillard d'Aignaux J, Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, Peoc'h K, Salomon D, Hauw JJ, Alperovitch A: Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7. J Neurol Neurosurg Psychiatry. 2000, 68: 787-789. 10.1136/jnnp.68.6.787.CrossRef
20.
go back to reference Arpino C, Conti S, Masocco M, Toccaceli V, Ladogana A, D'Alessandro M, Pocchiari M: Creutzfeldt-Jakob disease mortality in Italy, 1982-1996. Neuroepidemiology. 1999, 18: 92-100. 10.1159/000069412.CrossRefPubMed Arpino C, Conti S, Masocco M, Toccaceli V, Ladogana A, D'Alessandro M, Pocchiari M: Creutzfeldt-Jakob disease mortality in Italy, 1982-1996. Neuroepidemiology. 1999, 18: 92-100. 10.1159/000069412.CrossRefPubMed
21.
go back to reference Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alperovitch A: Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology. 2000, 54: 1095-1099.CrossRefPubMed Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alperovitch A: Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology. 2000, 54: 1095-1099.CrossRefPubMed
22.
go back to reference Saiz A, Nos C, Yagüe J, Domínguez A, Graus F, Muñoz P: The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia. J Neurol. 2001, 248: 592-594. 10.1007/s004150170137.CrossRefPubMed Saiz A, Nos C, Yagüe J, Domínguez A, Graus F, Muñoz P: The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia. J Neurol. 2001, 248: 592-594. 10.1007/s004150170137.CrossRefPubMed
23.
go back to reference Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer WJ, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichenberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA: Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999, 46: 224-233. 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W.CrossRefPubMed Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer WJ, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichenberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA: Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999, 46: 224-233. 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W.CrossRefPubMed
24.
go back to reference Kovács GG, Head MW, Bunn T, László L, Will RG, Ironside JW: Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 2000, 26: 463-472. 10.1046/j.1365-2990.2000.00279.x.CrossRefPubMed Kovács GG, Head MW, Bunn T, László L, Will RG, Ironside JW: Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 2000, 26: 463-472. 10.1046/j.1365-2990.2000.00279.x.CrossRefPubMed
25.
go back to reference Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schröter A, Henkel K, Tschampa HJ, Windl O, Pfahlberg A, Steinhoff BJ, Gefeller O, Kretzschmar HA, Poser S: Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol. 2000, 48: 323-329. 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5.CrossRefPubMed Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schröter A, Henkel K, Tschampa HJ, Windl O, Pfahlberg A, Steinhoff BJ, Gefeller O, Kretzschmar HA, Poser S: Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol. 2000, 48: 323-329. 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5.CrossRefPubMed
26.
go back to reference Alpérovitch A, Zerr I, Pocchiari M, Mitrová E, Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar HA, van Duijn CM, Will RG: Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 1999, 353: 1673-1674. 10.1016/S0140-6736(99)01342-2.CrossRefPubMed Alpérovitch A, Zerr I, Pocchiari M, Mitrová E, Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar HA, van Duijn CM, Will RG: Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 1999, 353: 1673-1674. 10.1016/S0140-6736(99)01342-2.CrossRefPubMed
Metadata
Title
Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002
Authors
Jesús de Pedro-Cuesta
Markus Glatzel
Javier Almazán
Katharina Stoeck
Vittorio Mellina
Maria Puopolo
Maurizio Pocchiari
Inga Zerr
Hans A Kretszchmar
Jean-Philippe Brandel
Nicole Delasnerie-Lauprêtre
Annick Alpérovitch
Cornelia Van Duijn
Pascual Sanchez-Juan
Steven Collins
Victoria Lewis
Gerard H Jansen
Michael B Coulthart
Ellen Gelpi
Herbert Budka
Eva Mitrova
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2006
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-6-278

Other articles of this Issue 1/2006

BMC Public Health 1/2006 Go to the issue